Huge crowds have come out to Chinatown for Lunar New Year as new political faces take office. She made the look her own with ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Palantir Technologies (NASDAQ:PLTR) has been described as the best pure-play stock in artificial intelligence. The market ...

Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed. The ...

Looking back at the 2018 freeze in Southeast Louisiana ...

Make gradual lifestyle changes to your diet and exercise routine to lose weight, including excess fat around your tummy, that you can maintain. Don’t trust over-the-counter pills or supplements ...

The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

Headache Medicine: What Should You Take? Medicines can help you manage, prevent, or end headache pain. There are many different treatment options available. Some medicines relieve headache pain ...

Eli Lilly and Company (NYSE:LLY) announced on Tuesday that the pharmaceuticals company expects Q4 2024 revenue to be ~$13.5B. The consensus revenue estimate stands at $13.95B. "While the U.S ...

"2024 was a pivotal and highly successful year for Lilly, and we expect to continue our momentum in 2025 with strong financial and operational performance," continued Ricks. "Sales of Mounjaro and ...

Global pharmaceutical company Eli Lilly's (LLY) preliminary 2024 revenue ... and they're going to have oral data for a pill, I think, sometime in the first half of this year [toward] the spring ...

Eli Lilly expects its experimental weight loss pill, orforglipron, to receive approval as early as next year, CEO David Ricks told Bloomberg Jan. 13. The company is preparing to release key late ...